|  |
 |
 |
 |
 |
| Stem cell profit rules urgedSacramento BeeJanuary 24th, 2006"Biotech companies that commercialize taxpayer-funded stem cell research would have to plan to sell the drugs at the "lowest available U.S. commercial price" to low-income Californians, a task force recommended Monday..." |
|
|
 |
 |
 |
 |
|  |
|